Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001213900-24-066053
Filing Date
2024-08-07
Accepted
2024-08-07 14:19:55
Documents
1
Period of Report
2024-08-07

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 6-K ea0210808-6ka1_scinai.htm 6-K/A 24464
  Complete submission text file 0001213900-24-066053.txt   25719
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-37353 | Film No.: 241182948
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)